Holen Sie sich die Stockscreener-App
0.518
5.80%
0.0284
Schlusskurs vom Vortag:
$0.4896
Offen:
$0.49
24-Stunden-Volumen:
908.39K
Relative Volume:
0.99
Marktkapitalisierung:
$44.63M
Einnahmen:
$2.24M
Nettoeinkommen (Verlust:
$-136.67M
KGV:
-0.2262
EPS:
-2.29
Netto-Cashflow:
$-102.08M
1W Leistung:
-7.17%
1M Leistung:
-13.71%
6M Leistung:
-30.72%
1J Leistung:
-68.80%
1-Tages-Spanne:
$0.48
$0.523
1-Wochen-Bereich:
$0.48
$0.57
52-Wochen-Spanne:
$0.3418
$2.05
Century Therapeutics Inc Stock (IPSC) Company Profile
Firmenname
Century Therapeutics Inc
Sektor
Branche
Telefon
215-981-4000
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Vergleichen Sie IPSC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.518 | 42.18M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-27 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-10-31 | Eingeleitet | Guggenheim | Buy |
| 2022-10-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-12 | Eingeleitet | William Blair | Mkt Perform |
| 2021-07-13 | Eingeleitet | BofA Securities | Buy |
| 2021-07-13 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-13 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten
Century Therapeutics Inc. Recovery Likely Here’s What Data ShowsExit Ready Momentum Stock Watchlist Expanded - 선데이타임즈
Earnings visualization tools for Century Therapeutics Inc.Long Term Stock Growth Plan Suggestions - Newser
Backtesting results for Century Therapeutics Inc. trading strategiesLong-Term Safety Investment Analysis Report - Newser
Measuring Century Therapeutics Inc.’s beta against major indicesDay Trading Setup Forecast with Trend Model - Newser
What institutions are buying Century Therapeutics Inc. stock nowBuy Strategy Review With Performance Summary - Newser
Philly’s biotech industry keeps losing local jobs in a volatile market - WHYY
Technical analysis overview for Century Therapeutics Inc. stockDay Trading Plan with Entry Risk Management - Newser
Is Century Therapeutics Inc. showing signs of accumulationTrade Setup Builder with Custom Alerts - Newser
Layoff Tracker: Bicycle, Tune, Iovance, Precision Downsize to Conserve Cash - BioSpace
How Century Therapeutics Inc. stock performs during market volatilityStock Trading Session Highlights and Summary - Newser
Century Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Breakout Traders Target Century Therapeutics Inc. on Recovery SetupVerified Signal From Chart Patterns Detected - beatles.ru
How does Century Therapeutics Inc. compare to its industry peersMaximize portfolio growth with expert advice - Jammu Links News
Century Therapeutics Inc. Stock Analysis and ForecastGet expert advice on portfolio optimization - Jammu Links News
Is Century Therapeutics Inc. a good long term investmentSkyrocketing returns - Jammu Links News
What catalysts could drive Century Therapeutics Inc. stock higher in 2025Build wealth faster with high-performing stocks - Jammu Links News
What are the technical indicators suggesting about Century Therapeutics Inc.Achieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for Century Therapeutics Inc.Capitalize on market trends before they peak - Jammu Links News
What are Century Therapeutics Inc. company’s key revenue driversRecord-breaking capital gains - Jammu Links News
How volatile is Century Therapeutics Inc. stock compared to the marketFree High-Return Strategy Alerts - Jammu Links News
Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting - MSN
Is Century Therapeutics Inc. stock overvalued or undervaluedDiscover hidden gems in the stock market - Jammu Links News
Comparing Praxsyn (OTCMKTS:PXYN) & Century Therapeutics (NASDAQ:IPSC) - Defense World
What makes Century Therapeutics Inc. stock price move sharplyRisk Managed Watchlist with Breakout Picks - Newser
How hedge fund analytics apply to Century Therapeutics Inc. stockHigh Reward Investment Strategy for Beginners - Newser
Century Therapeutics (NASDAQ:IPSC) versus Biomerica (NASDAQ:BMRA) Financial Comparison - Defense World
What is Century Therapeutics Inc. company’s growth strategyMarket Forecast Recommendation With Low Risk - Jammu Links News
Will Century Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsAsset Safety Selection Using Quantitative Analysis - Newser
Published on: 2025-07-30 19:14:22 - metal.it
Century Therapeutics (NASDAQ:IPSC) Shares Down 8.7% – Here’s Why - Defense World
Published on: 2025-07-29 18:11:16 - metal.it
Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):